It’s no secret that progress has left a lot of concepts, products, and practices in the dust. As technology progressed, society started embracing 8-hour work days, benefits, and even retirement plans. According to Richard Branson, the billionaire owner of Virgin, lab-grown meats will be the norm in a few years. In turn, slaughtering livestock for food will go the way of the slave trade and be considered “archaic.”
In a recent blog post that Branson himself wrote and put up on Virgin’s website, the billionaire explained why he invested in Memphis Meats and what he expects from artificial meat. The mogul noted how foolish it was that humans are still killing animals in order to live, given how raising livestock directly affects the environment.
Branson also acknowledged that giving up meat is not an option that everyone is comfortable with. As such, the solution is to simply find an alternative that will give consumers satisfaction with their protein cravings while avoiding raising and slaughtering livestock. The answer is artificial meat.
“I believe that in 30 years or so we will no longer need to kill any animals and that all meat will either be clean or plant-based, taste the same and also be much healthier for everyone. One day we will look back and think how archaic our grandparents were in killing animals for food,” the post reads.
The billionaire is not the only influential figure who is looking at the prospect of lab-grown meats as alternative sources of sustenance, Futurism reports. Microsoft Founder Bill Gates has also thrown his hat in the cruelty-free ring, along with Kimball Musk.
Even the Chinese government is looking to spend hundreds of millions of dollars in order to reduce carbon emissions from raising livestock by partnering with Israeli companies creating artificial meat. As electric vehicles and autonomous driving are taking over the car industry, it’s looking like lab-grown meat might also take over the food industry.


Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Neuralink Expands Brain Implant Trials with 12 Global Patients
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 



